Latest deal DXB negotiated +30% royalties. Yes +30% which is phenomenal. So now we have 2 independent parties thoroughly reviewed the clinical data and said yes and more deals to come. Now getting back to that +30% royalties obvious to me DXB huge cash pile upfront payments not their main objective in future deals but maximizing the return on each drug sale very exciting times ahead.
Latest deal DXB negotiated +30% royalties. Yes +30% which is...
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
0.020(3.92%) |
Mkt cap ! $291.6M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 53.8¢ | 51.0¢ | $782.0K | 1.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6408 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 35657 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |